Ironwood Pharmaceuticals

(NASDAQ) IRWD

Current Price$4.22

Market Cap$679.95M

Since IPO (2010)-57%

5 Year-62%

1 Year+427%

1 Month+21%

Ironwood Pharmaceuticals Financials at a Glance

Market Cap

$679.95M

Revenue (TTM)

$361.51M

Net Income (TTM)

$150.97M

EPS (TTM)

$0.12

P/E Ratio

34.61

Dividend

$0.00

Beta (Volatility)

0.67 (Low)

Dividend

$0.00

Beta (Volatility)

0.67 (Low)

Price

$4.22

Volume

101,607

Open

$4.24

Price

$4.22

Volume

101,607

Open

$4.24

Previous Close

$4.22

Daily Range

$4.00 - $4.35

52-Week Range

$0.53 - $5.78

Dividend

$0.00

Beta (Volatility)

0.67 (Low)

Price

$4.22

Volume

101,607

Open

$4.24

Previous Close

$4.22

Daily Range

$4.00 - $4.35

52-Week Range

$0.53 - $5.78

IRWD News

3 Great Stocks Under $10

Will HealySep 27, 2020

Is Ironwood Pharmaceuticals Stock a Buy?

David Jagielski, CPAFeb 12, 2020

woman holding picture with a smiling colon

Ironwood Pharmaceuticals' Blowout Q2 Results: What You'll Want to Know

Keith SpeightsJul 31, 2019

Here's Why Ironwood Pharmaceuticals Rose as Much as 12% Today

Maxx ChatskoMay 17, 2019

Page 1

IRWD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ironwood Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

100

CEO

Thomas A. McCourt

Website

www.ironwoodpharma.com

Headquarters

Boston, MA 02110, US

IRWD Financials

Key Financial Metrics (TTM)

Gross Margin

70%

Operating Margin

55%

Net Income Margin

42%

Return on Equity

Return on Capital

Return on Assets

35%

Earnings Yield

2.89%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$679.95M

Shares Outstanding

163.06M

Volume

101.61K

Avg. Volume

2.83M

Financials (TTM)

Gross Profit

$294.27M

Operating Income

$118.76M

EBITDA

$104.65M

Operating Cash Flow

$127.04M

Capital Expenditure

$34.00K

Free Cash Flow

$127.01M

Cash & ST Invst.

$215.46M

Total Debt

$597.80M

Ironwood Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$106.51M

+158.9%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$679.95M

N/A

Market Cap/Employee

$2.69M

N/A

Employees

253

N/A

Net Income

$89.57M

+339.6%

EBITDA

$72.57M

+820.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$8.12M

+101.7%

Accounts Receivable

$105.84M

+166.1%

Inventory

$0.00

N/A

Long Term Debt

$209.09M

-64.9%

Short Term Debt

$3.27M

+2.0%

Return on Assets

34.74%

N/A

Return on Invested Capital

1.01%

N/A

Free Cash Flow

$0.00

-100.0%

Operating Cash Flow

$0.00

-100.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BIOABioAge Labs, Inc.

BIOABioAge Labs, Inc.$17.99+0.95%

NPCENeuroPace, Inc.

NPCENeuroPace, Inc.$18.35-4.87%

CGCCanopy Growth Corporation

CGCCanopy Growth Corporation$1.11-1.77%

CLLSCellectis S.A.

CLLSCellectis S.A.$3.85-0.26%

SLNSilence Therapeutics plc

SLNSilence Therapeutics plc$6.97+0.29%

TKNOAlpha Teknova, Inc.

TKNOAlpha Teknova, Inc.$3.83-4.25%

ACBAurora Cannabis Inc.

ACBAurora Cannabis Inc.$3.41-0.58%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

NOKNokia

NOKNokia$12.82+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.35+0.01%

BBBlackBerry

BBBlackBerry$6.37+0.04%

Questions About IRWD

What is the current price of Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals is trading at $4.22 per share.

What is the 52-week range for Ironwood Pharmaceuticals?

Over the past 52 weeks, Ironwood Pharmaceuticals has traded between $0.53 and $5.78.

How much debt does Ironwood Pharmaceuticals have?

As of the most recent reporting period, Ironwood Pharmaceuticals reported total debt of $597.36M.

How much cash does Ironwood Pharmaceuticals have on hand?

Ironwood Pharmaceuticals reported $220.47M in cash and cash equivalents in its most recent financial results.

What is Ironwood Pharmaceuticals’s dividend yield?

Ironwood Pharmaceuticals does not currently have a dividend yield.

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals Financials at a Glance

IRWD News

Ironwood (IRWD) Q2 EPS Jumps 600%

Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround

Why Ironwood Pharmaceuticals Stock Bumped Higher Today

3 No-Brainer Stocks to Buy Right Now for Less Than $25

3 Great Stocks Under $10

Is Ironwood Pharmaceuticals Stock a Buy?

Ironwood Pharmaceuticals' Blowout Q2 Results: What You'll Want to Know

Here's Why Ironwood Pharmaceuticals Rose as Much as 12% Today

IRWD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ironwood Pharmaceuticals

IRWD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ironwood Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IRWD

What is the current price of Ironwood Pharmaceuticals?

What is the 52-week range for Ironwood Pharmaceuticals?

How much debt does Ironwood Pharmaceuticals have?

How much cash does Ironwood Pharmaceuticals have on hand?

What is Ironwood Pharmaceuticals’s dividend yield?

Premium Investing Services